Evaluating the potential benefit of interferon treatment in multiple sclerosis.
Tobias
T
Derfuss
Ludwig
L
Kappos
D006233:Persons with Disabilities; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D016899:Interferon-beta / Q000627:therapeutic use*; D008297:Male; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy* / Q000503:physiopathology*
D007155:Immunologic Factors; D016899:Interferon-beta